Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1945]
News [3579]
Articles [92]
Editorials [5]
Conferences [157]
elearning [19]
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?
Prof Michael Seckl - Imperial College London, London
Prof Michael Seckl: Why attend Future Horizons in Lung Cancer? ( Prof Michael Seckl - Imperial College London, London )
17 Jul 2016
Regulation of T cells in tissues and tumours
Prof Adrian Hayday - King's College London, London, UK
Regulation of T cells in tissues and tumours ( Prof Adrian Hayday - King's College London, London, UK )
13 Jul 2016
Cured AML patients generate anti-tumour antibodies that kill AML blasts
Dr Mette Hazenberg - Academic Medical Center, Amsterdam, The Netherlands
Cured AML patients generate anti-tumour antibodies that kill AML blasts ( Dr Mette Hazenberg - Academic Medical Center, Amsterdam, The Netherlands )
6 Jul 2016
Combination trial designs: efficient, effective and tolerable regimens
Dr Susan Galbraith – AstraZeneca, Macclesfield, UK
Combination trial designs: efficient, effective and tolerable regimens ( Dr Susan Galbraith – AstraZeneca, Macclesfield, UK )
4 Jul 2016
Patient perspectives in precision medicine: 'No innovation about us without us'
Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium
Patient perspectives in precision medicine: 'No innovation about us without us' ( Dr Francesco de Lorenzo - European Cancer Patient Coalition, Brussels, Belgium )
4 Jul 2016
WIN 2016 highlights: Changing the understanding of cancer
Prof Richard Schilsky - Chief Medical Officer of the American Society of...
WIN 2016 highlights: Changing the understanding of cancer ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )
1 Jul 2016
Editor's Choice for June 2016
Prof Gordon McVie - ecancer Editor in Chief
Editor's Choice for June 2016 ( Prof Gordon McVie - ecancer Editor in Chief )
29 Jun 2016
Editor's ASCO 2016 Roundup
Prof Gordon McVie - ecancer Editor in Chief
Editor's ASCO 2016 Roundup ( Prof Gordon McVie - ecancer Editor in Chief )
16 Jun 2016
Latest in precision cancer medicine
Prof Richard Schilsky - Chief Medical Officer, ASCO
Latest in precision cancer medicine ( Prof Richard Schilsky - Chief Medical Officer, ASCO )
15 Jun 2016
CD19 CAR T-cells effective with with low dose chemotherapy.
Dr Stephanie Goff - National Cancer Institute, Bethesda, USA
CD19 CAR T-cells effective with with low dose chemotherapy. ( Dr Stephanie Goff - National Cancer Institute, Bethesda, USA )
12 Jun 2016
PD-1 enhances elotuzumab efficacy
Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA
PD-1 enhances elotuzumab efficacy ( Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA )
12 Jun 2016
The latest in CLL from EHA 2016
Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam
The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )
11 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation